Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


Recap: American Bar Association’s antitrust meeting

New leaders highlight their prospective plans

Last week, the American Bar Association (ABA) held its 61st annual spring antitrust meeting, which this year attracted a record crowd of more than 2,700 attendees. The meeting, which took place in Washington, D.C., was an opportunity for new antitrust leaders to preview their plans and what they’ll focus on in their roles.

Bill Baer, who was confirmed Dec. 30, 2012, as assistant attorney general for the Department of Justice’s (DOJ) Antitrust Division, announced on Friday a policy change that will be a boon to corporate defendants. The policy stipulates that when companies enter into price-fixing plea deals with the DOJ, the written agreements will no longer publicly identify executives who may be subject to prosecution.

“Absent some significant justification, it is ordinarily not appropriate to publicly identify uncharged third-party wrongdoers,” Baer said in a written statement released shortly before he took the ABA stage.

Federal Trade Commission (FTC) Chairwoman Edith Ramirez, who assumed her position in March, also spoke about her agency’s antitrust plans. She told the ABA audience on Friday that she expects the FTC will continue to focus on antitrust issues in the health care and technology sectors while remaining active on consumer-protection and privacy issues.

Read the Wall Street Journal for more about the ABA antitrust meeting.

For more recent antitrust-related coverage from InsideCounsel, read:

Retail association opts out of billion-dollar settlement

MasterCard faces EU antitrust probe

Anheuser-Busch, DOJ reportedly close to $20 billion merger deal

Antitrust case against Minor League Baseball can proceed in Florida

Panelists discuss whether pay-for-delay settlements violate antitrust laws

Generic-drug makers sue brand-name companies for product samples

Intel uses Supreme Court Comcast ruling in its own antitrust case

How antitrust authorities view mergers and acquisitions

Google emerges from FTC antitrust probe largely unscathed

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.